References
- Acharya S, Dilnawaz F, Sahoo SK (2009). Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy. Biomaterials, 30, 5737-50. https://doi.org/10.1016/j.biomaterials.2009.07.008
- Acharya S, Sahoo SK (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev, 63, 170-83. https://doi.org/10.1016/j.addr.2010.10.008
- Adams GP, Schier R, McCall AM, et al (2001). High affinity restricts the localization and tumor penetration of singlechain fv antibody molecules. Cancer Res, 61, 4750-5.
- Agrahari V, Kabra V, Trivedi P. Development, Optimization and Characterization of Nanoparticle Drug Delivery System of Cisplatin, Springer pp 1325-8.
- Akbarzadeh A, Mikaeili H, Zarghami N, et al (2012a). Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine, 7, 511.
- Akbarzadeh A, Rezaei-Sadabady R, Davaran S,et al (2013). Liposome: classification, preparation, and applications. Nanoscale Res Lett, 8, 1-9. https://doi.org/10.1186/1556-276X-8-1
- Akbarzadeh A, Samiei M, Davaran S (2012b). Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett, 7, 1-13. https://doi.org/10.1186/1556-276X-7-1
- Akbarzadeh A, Samiei M, Joo SW, et al (2012c). Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnol, 10, 46. https://doi.org/10.1186/1477-3155-10-46
- Akbarzadeh A, Zarghami N, Mikaeili H, et al (2012d). Synthesis, characterization, and in vitro evaluation of novel polymercoated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl, 5, 13-25.
- Alexis F, Venkatraman SS, Rath SK, Boey F (2004). In vitro study of release mechanisms of paclitaxel and rapamycin from drug-incorporated biodegradable stent matrices. J Control Release, 98, 67-74. https://doi.org/10.1016/j.jconrel.2004.04.011
- Allemann E, Gurny R, Doelker E (1993). Drug-loaded nanoparticles: preparation methods and drug targeting issues. Eur J Pharm Biopharm, 39, 173-91.
- Allen TM (2002). Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer, 2, 750-63. https://doi.org/10.1038/nrc903
- Alonso MJ, Losa C, Calvo P, Vila-Jato JL (1991). Approaches to improve the association of amikacin sulphate to poly (alkylcyanoacrylate) nanoparticles. Int J Pharm, 68, 69-76. https://doi.org/10.1016/0378-5173(91)90128-B
- Alyautdin R, Gothier D, Petrov V, Kharkevich D, Kreuter J (1995). Analgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly (butyl cyanoacrylate) nanoparticles. Eur J Pharm Biopharm, 41, 44-8.
- Alyautdin RN, Tezikov EB, Ramge P, et al (1998). Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study. J Microencapsul, 15, 67-74. https://doi.org/10.3109/02652049809006836
- Ambudkar SV, Kimchi-Sarfaty C, Sauna Z.E, Gottesman MM (2003). P-glycoprotein: from genomics to mechanism. Oncogene, 22, 7468-85. https://doi.org/10.1038/sj.onc.1206948
- Anand P, Nair HB, Sung B, et al (2010). Design of curcuminloaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity< i> in vitro and superior bioavailability< i> in vivo. Biochem pharmacol. 79, 330-8. https://doi.org/10.1016/j.bcp.2009.09.003
- Araujo L, Lobenberg R, Kreuter J (1999). Influence of the surfactant concentration on the body distribution of nanoparticles. J Drug Targeting, 6, 373-85. https://doi.org/10.3109/10611869908996844
- Astete CE, Sabliov CM (2006). Synthesis and characterization of PLGA nanoparticles. J Biom Sci, Polymer Edition, 17, 247-89. https://doi.org/10.1163/156856206775997322
- Avgoustakis K, Beletsi A, Panagi Z, et al (2002). PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release, 79, 123-35. https://doi.org/10.1016/S0168-3659(01)00530-2
- Bala I, Hariharan S, Kumar MN (2004). PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst, 21, 387. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v21.i5.20
- Betancourt T, Brown B, Brannon-Peppas L (2007). Doxorubicinloaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine, 2, 219-32. https://doi.org/10.2217/17435889.2.2.219
- Bilati U, Allemann E, Doelker E (2005). Strategic approaches for overcoming peptide and protein instability within biodegradable nano-and microparticles. Eur J Pharm Biopharm, 59, 375-88. https://doi.org/10.1016/j.ejpb.2004.10.006
- Bishara A, Domb AJ (2005). PLA stereocomplexes for controlled release of somatostatin analogue. J Control Release, 107, 474-83. https://doi.org/10.1016/j.jconrel.2005.05.026
- Bisht S, Feldmann G, Soni S, et al (2007). Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnol, 5, 1-18. https://doi.org/10.1186/1477-3155-5-1
- Borst P, Zelcer N, Van de Wetering K, Poolman B (2006). On the putative co-transport of drugs by multidrug resistance proteins. FEBS Lett, 580, 1085-93. https://doi.org/10.1016/j.febslet.2005.12.039
- Brigger I, Dubernet C, Couvreur P (2002). Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev, 54, 631-51. https://doi.org/10.1016/S0169-409X(02)00044-3
- Butoescu N, Seemayer CA, Foti M, Jordan O, Doelker E (2009). Dexamethasone-containing PLGA superparamagnetic microparticles as carriers for the local treatment of arthritis. Biomaterials, 30, 1772-80. https://doi.org/10.1016/j.biomaterials.2008.12.017
- Byrne JD, Betancourt T, Brannon-Peppas L (2008). Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev, 60, 1615-26. https://doi.org/10.1016/j.addr.2008.08.005
- Calvo P, Gouritin B, Brigger I, et al (2001). PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases. J Neuroscience Methods, 111, 151-5. https://doi.org/10.1016/S0165-0270(01)00450-2
- Carmeliet P (2005). VEGF as a key mediator of angiogenesis in cancer, Oncol, 69, 4-10. https://doi.org/10.1159/000088478
- Chacon M, Molpeceres J, Berges L, et al (1999). Stability and freeze-drying of cyclosporine loaded poly (D, L lactide- glycolide) carriers. Eur J Pharm Sci, 8, 99-107. https://doi.org/10.1016/S0928-0987(98)00066-9
- Chan S, Scheulen ME, Johnston S, et al (2005). Phase II study of temsirolimus (CCI-779), a novel inhibitor of mTOR, in heavily pretreated patients with locally advanced or metastatic breast cancer. J Clin Oncol, 23, 5314-22. https://doi.org/10.1200/JCO.2005.66.130
- Cheng FY, Wang SPH, Su CH, et al (2008). Stabilizer-free poly (lactide-< i> co-glycolide) nanoparticles for multimodal biomedical probes. Biomaterials, 29, 2104-12. https://doi.org/10.1016/j.biomaterials.2008.01.010
- Cheng J, Teply BA, Sherifi I, et al (2007). Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials, 28, 869-76. https://doi.org/10.1016/j.biomaterials.2006.09.047
- Cheng L, Jin C, Lv W, Ding Q, Han X (2011). Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer. PloS One, 6, 25433. https://doi.org/10.1371/journal.pone.0025433
- Cho K, Wang X, Nie S, Shin DM (2008). Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res, 14, 1310-6. https://doi.org/10.1158/1078-0432.CCR-07-1441
- Choi SW, Kim JH (2007). Design of surface-modified poly (D, L-lactide-co-glycolide) nanoparticles for targeted drug delivery to bone. J Control Releas, 122, 24-30. https://doi.org/10.1016/j.jconrel.2007.06.003
- Couvreur P, Dubernet C, Puisieux F (1995). Controlled drug delivery with nanoparticles: current possibilities and future trends. Eur J Pharm Biopharm, 41, 2-13.
- D'Souza SS, Selmin F, Murty SB, et al (2004). Assessment of fertility in male rats after extended chemical castration with a GnRH antagonist. The AAPS J, 6, 94-9.
- D'Mello SR, Das SK, Das NG. Polymeric Nanoparticles for Small-Molecule Drugs: Biodegradation of Polymers and Fabrication of Nanoparticles. Drug Delivery Nanoparticles Formulation and Characterization: 16.
- D'Souza SS, Faraj JA, DeLuca PP (2005). A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech, 6, 553-64. https://doi.org/10.1208/pt060470
- Danhier F, Ansorena E, Azeitao J, et al (2012). PLGA-based nanoparticles: An overview of biomedical applications. J Control Release, 161, 505-22. https://doi.org/10.1016/j.jconrel.2012.01.043
- Danhier F, Feron O, Preat V (2010). To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release, 148, 135-46. https://doi.org/10.1016/j.jconrel.2010.08.027
- Danhier F, Lecouturier N, Vroman B, et al (2009). Paclitaxelloaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release, 133, 11-7. https://doi.org/10.1016/j.jconrel.2008.09.086
- Daniels TR, Delgado T, Helguera G, Penichet ML (2006). The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clinical Immunol, 121, 159-76. https://doi.org/10.1016/j.clim.2006.06.006
- Davis FF (2002). The origin of pegnology. Advanced Drug Delivery Reviews, 54, 457-8. https://doi.org/10.1016/S0169-409X(02)00021-2
- Davis ME (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov, 7,771-82. https://doi.org/10.1038/nrd2614
- Derakhshandeh K, Erfan M, Dadashzadeh S (2007). Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: factorial design, characterization and release kinetics. Eur J Pharm Biopharm,, 66, 34-41. https://doi.org/10.1016/j.ejpb.2006.09.004
- Desai KGH, Olsen KF, Mallery SR, Stoner GD, Schwendeman SP (2010). Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins. Pharm Res, 27, 628-43. https://doi.org/10.1007/s11095-009-0038-5
- Desgrosellier JS, Cheresh DA (2010). Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer, 10, 9-22. https://doi.org/10.1038/nrc2748
- Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F (2011). Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine, 6, 877.
- Dong WY, Korber M, Lopez Esguerra V, Bodmeier R (2006). Stability of poly (D, L-lactide-co-glycolide). and leuprolide acetate in in-situ forming drug delivery systems. J Control Release, 115, 158-67. https://doi.org/10.1016/j.jconrel.2006.07.013
- Dong Y, Feng SS (2005). Poly (d, l-lactide-co-glycolide)./montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26, 6068-76. https://doi.org/10.1016/j.biomaterials.2005.03.021
- Dorta MJ, Santovena A, Llabres M, Farina JB (2002). Potential applications of PLGA film-implants in modulating in vitro drugs release. Int J Pharm, 248, 149-56. https://doi.org/10.1016/S0378-5173(02)00431-3
- Duncan R (2003). The dawning era of polymer. Nat Rev Drug Discov, 2, 347. https://doi.org/10.1038/nrd1088
- Dunne M, Corrigan OI, Ramtoola Z (2000). Influence of particle size and dissolution conditions on the degradation properties of polylactide-< i> co-glycolide particles. Biomaterials 21, 1659-68. https://doi.org/10.1016/S0142-9612(00)00040-5
- Esmaeili F, Atyabi F, Dinarvand R (2007a). Preparation of PLGA nanoparticles using TPGS in the spontaneous emulsification solvent diffusion method. J Experim Nanosci, 2, 183-92. https://doi.org/10.1080/17458080701393137
- Esmaeili F, Ghahremani MH, Esmaeili B, et al (2008a). PLGA nanoparticles of different surface properties: Preparation and evaluation of their body distribution. Int J Pharm, 349, 249-55. https://doi.org/10.1016/j.ijpharm.2007.07.038
- Esmaeili F, Ghahremani MH, Ostad SN, Atyabi F, Seyedabadi M, Malekshahi M.R, Amini M, Dinarvand R (2008b). Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugate. J Drug Targeting, 16, 415-23. https://doi.org/10.1080/10611860802088630
- Esmaeili F, Hosseini-Nasr M, Rad-Malekshahi M, et al (2007b). Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles. Nanomedicine: Nanotechnol, Biol and Med, 3, 161-7. https://doi.org/10.1016/j.nano.2007.03.003
- Feng SS (2004). Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Dev, 1, 115-25. https://doi.org/10.1586/17434440.1.1.115
- Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S (1989). Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm, 55, R1-R4. https://doi.org/10.1016/0378-5173(89)90270-6
- Foged C, Brodin B, Frokjaer S, Sundblad A (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm, 298, 315-22. https://doi.org/10.1016/j.ijpharm.2005.03.035
- Fojo AT, Ueda K, Slamon DJ, et al (1987). Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci, 84, 265-9. https://doi.org/10.1073/pnas.84.1.265
- Folkman J (1971). Transplacental carcinogenesis by stilbestrol. The New England J Med, 285, 404. https://doi.org/10.1056/NEJM197108122850711
- Fonseca C, Simoes S, Gaspar R (2002). Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release, 83, 273-86. https://doi.org/10.1016/S0168-3659(02)00212-2
- Fredenberg S, Wahlgren M, Reslow M, Axelsson A (2011). The mechanisms of drug release in poly (lactic-co-glycolic acid).-based drug delivery systems-A review. Int J Pharm, 415, 34-52. https://doi.org/10.1016/j.ijpharm.2011.05.049
- Friess W, Schlapp M (2002). Release mechanisms from gentamicin loaded poly (lactic-co-glycolic acid)(PLGA) microparticles. J Pharm Sci, 91, 845-55. https://doi.org/10.1002/jps.10012
- Gagliardi M, Silvestri D, Cristallini C, et al (2010). Combined drug release from biodegradable bilayer coating for endovascular stents. J Biomed Materials Res Part B: Applied Biomaterials, 93, 375-85.
- Garber K (2001). Rapamycin may prevent post-transplant lymphoma. J Natl Cancer Inst, 93, 1519. https://doi.org/10.1093/jnci/93.20.1519
- Garinot M, Fievez V, Pourcelle V, et al (2007). PEGylated PLGAbased nanoparticles targeting M cells for oral vaccination. J Control Release, 120, 195-204. https://doi.org/10.1016/j.jconrel.2007.04.021
- Gaumet M, Vargas A, Gurny R, Delie F (2008). Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm, 69, 1-9. https://doi.org/10.1016/j.ejpb.2007.08.001
- Gelperina S, Maksimenko O, Khalansky A, et al (2010). Drug delivery to the brain using surfactant-coated poly (lactideco-glycolide) nanoparticles: influence of the formulation parameters. Eur J Pharm Biopharm, 74, 157-63. https://doi.org/10.1016/j.ejpb.2009.09.003
- Gelperina SE, Khalansky AS, Skidan IN, et al (2002). Toxicological studies of doxorubicin bound to polysorbate 80-coated poly (butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma. Toxicol lett, 126, 131-41. https://doi.org/10.1016/S0378-4274(01)00456-8
- Genis L, Galvez BG, Gonzalo P, Arroyo AG (2006). MT1-MMP: Universal or particular player in angiogenesis? Cancer and Metastasis Rev, 25, 77-86. https://doi.org/10.1007/s10555-006-7891-z
- Gomez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E (2007). Encapsulation of dexamethasone into biodegradable polymeric nanoparticles. Int J Pharm, 331, 153-9. https://doi.org/10.1016/j.ijpharm.2006.11.028
- Gosk S, Moos T, Gottstein C, Bendas G (2008). VCAM-1 directed immunoliposomes selectively target tumor vasculature< i> in vivo. (BBA)-Biomembranes, 1778, 854-63. https://doi.org/10.1016/j.bbamem.2007.12.021
- Govender T, Stolnik S, Garnett MC, Illum L, Davis SS (1999). PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release, 57, 171-85. https://doi.org/10.1016/S0168-3659(98)00116-3
- Gref R, Luck M, Quellec P, et al (2000). 'Stealth'corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids and surfaces. B, Biointerfaces, 18, 301. https://doi.org/10.1016/S0927-7765(99)00156-3
- Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K (2007). Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur J Pharm Biopharm, 67, 1-8. https://doi.org/10.1016/j.ejpb.2006.12.017
- Haddadi A, Elamanchili P, Lavasanifar A, et al (2008). Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. J Biomed Materials Res Part A, 84, 885-98.
- Hans ML, Lowman AM (2002). Biodegradable nanoparticles for drug delivery and targeting. Current Opinion Solid State Mater Sci, 6, 319-27. https://doi.org/10.1016/S1359-0286(02)00117-1
- Hidalgo M, Rowinsky EK (2000). The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene, 19, 6680. https://doi.org/10.1038/sj.onc.1204091
- Hillaireau H, Couvreur P (2009). Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci, 66, 2873-96. https://doi.org/10.1007/s00018-009-0053-z
- Houchin ML, Topp EM (2008). Chemical degradation of peptides and proteins in PLGA: a review of reactions and mechanisms. J Pharm sci, 97, 2395-404. https://doi.org/10.1002/jps.21176
- Ibrahim H, Bindschaedler C, Doelker E, Buri P, Gurny R (1992). Aqueous nanodispersions prepared by a salting-out process. Int J Pharm, 87, 239-46. https://doi.org/10.1016/0378-5173(92)90248-Z
- Jain RA (2000). The manufacturing techniques of various drug loaded biodegradable poly (lactide-< i> co-glycolide) (PLGA) devices. Biomaterials, 21, 2475-90. https://doi.org/10.1016/S0142-9612(00)00115-0
- Jain RK (1989). Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J Natl Cancer Inst, 81, 570-76. https://doi.org/10.1093/jnci/81.8.570
- Jain RK (1999). Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clinical Cancer Res, 5, 1605-06.
- Jain RK (2001). Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function. J Control Release, 74, 7-25. https://doi.org/10.1016/S0168-3659(01)00306-6
- Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: A cancer J clinicians, 61, 69-90. https://doi.org/10.3322/caac.20107
- Jin C, Bai L, Wu H, Song W, Guo G, Dou K (2009). Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells. Pharm Res, 26, 1776-84. https://doi.org/10.1007/s11095-009-9889-z
- Johnson OFL, Jaworowicz W, Cleland JL, et al (1997). The stabilization and encapsulation of human growth hormone into biodegradable microspheres. Pharm Res, 14, 730-5. https://doi.org/10.1023/A:1012142204132
- Jonnalagadda S, Robinson DH (2000). A bioresorbable, polylactide reservoir for diffusional and osmotically controlled drug delivery. AAPS Pharm Sci Tech, 1, 26-34.
- Jung T, Kamm W, Breitenbach A, et al (2000). Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake? Eur J Pharm Biopharm, 50, 147-60. https://doi.org/10.1016/S0939-6411(00)00084-9
- Kalaria DR, Sharma G, Beniwal V, Ravi Kumar MN (2009). Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm Res, 26, 492-501. https://doi.org/10.1007/s11095-008-9763-4
- Kang J, Schwendeman SP (2007). Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. Molecular Pharm, 4, 104-18. https://doi.org/10.1021/mp060041n
- Kim HK, Chung HJ, Park TG (2006). Biodegradable polymeric microspheres with “open/closed” pores for sustained release of human growth hormone. J Control Release, 112, 167-74. https://doi.org/10.1016/j.jconrel.2006.02.004
- Kim SH, Jeong JH, Chun KW, Park TG (2005). Target-specific cellular uptake of PLGA nanoparticles coated with poly (L-lysine)-poly (ethylene glycol)-folate conjugate. Langmuir 21, 8852-7. https://doi.org/10.1021/la0502084
- Kirpotin DB, Drummond DC, Shao Y, et al (2006). Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res, 66, 6732-40. https://doi.org/10.1158/0008-5472.CAN-05-4199
- Klose D, Siepmann F, Elkharraz K, Siepmann J (2008). PLGAbased drug delivery systems: Importance of the type of drug and device geometry. Int J Pharm, 354, 95-103. https://doi.org/10.1016/j.ijpharm.2007.10.030
- Kohno K, Sato S, Takano H, Matsuo K, Kuwano M (1989). The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun,, 165, 1415-21. https://doi.org/10.1016/0006-291X(89)92761-7
- Konan Y.N, Gurny R, Allemann E (2002). Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles. Int J Pharm, 233, 239-52. https://doi.org/10.1016/S0378-5173(01)00944-9
- Kreuter J, Petrov V.E, Kharkevich D.A, Alyautdin R.N (1997). Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood-brain barrier using surfactant-coated nanoparticles. J Control Release, 49, 81-7. https://doi.org/10.1016/S0168-3659(97)00061-8
- Kumari A, Yadav SK, Yadav SC (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Colloids and Surfaces B: Biointerfaces, 75, 1-18. https://doi.org/10.1016/j.colsurfb.2009.09.001
- Labhasetwar V, Song C, Levy RJ (1997). Nanoparticle drug delivery system for restenosis. Advanc Drug Deliv Rev, 24, 63-85. https://doi.org/10.1016/S0169-409X(96)00483-8
- Lagarce F, Renaud P, Faisant N, et al (2005). Baclofen-loaded microspheres: preparation and efficacy testing in a new rabbit model. Eur J Pharm Biopharm, 59, 449-59. https://doi.org/10.1016/j.ejpb.2004.08.013
- Lam XM, Duenas ET, Daugherty AL, Levin N, Cleland JL (2000). Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. J Control Release, 67, 281-92. https://doi.org/10.1016/S0168-3659(00)00224-8
- Lambert G, Fattal E, Couvreur P (2001). Nanoparticulate systems for the delivery of antisense oligonucleotides. Advanc Drug Deliv Rev, 47, 99-112. https://doi.org/10.1016/S0169-409X(00)00116-2
- Lammers T, Hennink WE, Storm G (2008). Tumour-targeted nanomedicines: principles and practice. British J Cancer, 99, 392-7. https://doi.org/10.1038/sj.bjc.6604483
- Lamprecht A, Ubrich N, Yamamoto H, et al (2001). Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharm and Experimen Therapeutics, 299, 775-81.
- Langer R (1998). Drug delivery and targeting. Nature, 392, 5.
- Langer R, Folkman J (1976). Polymers for the sustained release of proteins and other macromolecules.
- Lee ES, Na K, Bae YH (2005). Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor. J Control Release: official, J Control Release Socie, 103, 405. https://doi.org/10.1016/j.jconrel.2004.12.018
- Li B, Xu H, Li Z, et al (2012). Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies. Int J Nanomedicine, 7, 187.
- Li Y, Pei Y, Zhang X, et al (2001). PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release, 71, 203. https://doi.org/10.1016/S0168-3659(01)00218-8
- Liu Y, Miyoshi H, Nakamura M (2007). Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer, 120, 2527-37. https://doi.org/10.1002/ijc.22709
- Low PS, Kularatne SA (2009). Folate-targeted therapeutic and imaging agents for cancer. Curr Opin Chem Biol, 13, 256-62. https://doi.org/10.1016/j.cbpa.2009.03.022
- Lu J.M, Wang X, Marin-Muller C, et al (2009). Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn, 9, 325-41. https://doi.org/10.1586/erm.09.15
- Lurje G, Lenz HJ (2009). EGFR signaling and drug discovery. Oncol, 77, 400-10. https://doi.org/10.1159/000279388
- Ma Y, Zheng Y, Liu K, et al (2010). Nanoparticles of poly (lactide-co-glycolide)-da-tocopheryl polyethylene glycol 1000 succinate random copolymer for cancer treatment. Nanoscale Res Lett, 5, 1161-9. https://doi.org/10.1007/s11671-010-9620-3
- Maeda H, Bharate GY, Daruwalla J (2009). Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm, 71, 409-19. https://doi.org/10.1016/j.ejpb.2008.11.010
- Maeda H, Sawa T, Konno T (2001). Mechanism of tumortargeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release, 74, 47-61. https://doi.org/10.1016/S0168-3659(01)00309-1
- Mahapatro A, Singh DK (2011). Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol, 9, 55. https://doi.org/10.1186/1477-3155-9-55
- Manuela Gaspar M, Blanco D, Cruz MEM, Jose Alonso M (1998). Formulation of L-asparaginase-loaded poly (lactideco-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. J Control Release, 52, 53-62. https://doi.org/10.1016/S0168-3659(97)00196-X
- Matsumoto A, Matsukawa Y, Horikiri Y, Suzuki T (2006). Rupture and drug release characteristics of multi-reservoir type microspheres with poly (dl-lactide-< i> co-glycolide) and poly (dl-lactide). Int J Pharm, 327, 110-6. https://doi.org/10.1016/j.ijpharm.2006.07.055
- Matsumura Y, Maeda H (1986). A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res, 46, 6387-92.
- Mattheolabakis G, Taoufik E, Haralambous S, Roberts ML, Avgoustakis K (2009). In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles. Eur J Pharm Biopharm, 71, 190-5. https://doi.org/10.1016/j.ejpb.2008.09.011
- Minko T (2004). Drug targeting to the colon with lectins and neoglycoconjugates. Advanc Drug Deliv Rev, 56, 491-509. https://doi.org/10.1016/j.addr.2003.10.017
- Misra R, Sahoo SK (2010). Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy. Eur J Pharm Sci, 39, 152-63. https://doi.org/10.1016/j.ejps.2009.11.010
- Mittal G, Sahana DK, Bhardwaj V, Ravi Kumar MNV (2007). Estradiol loaded PLGA nanoparticles for oral administration: Effect of polymer molecular weight and copolymer composition on release behavior< i> in vitro and< i> in vivo. J Control Release, 119, 77-85. https://doi.org/10.1016/j.jconrel.2007.01.016
- Mo Y, Lim LY (2005). Preparation and in vitro anticancer activity of wheat germ agglutinin (WGA)-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J Control Release, 107, 30-42. https://doi.org/10.1016/j.jconrel.2004.06.024
- Mochizuki A, Niikawa T, Omura I, Yamashita S (2008). Controlled release of argatroban from PLA film-Effect of hydroxylesters as additives on enhancement of drug release. J Appl Polymer Sci, 108, 3353-60. https://doi.org/10.1002/app.27970
- Moghimi SM, Hunter AC (2000). Poloxamers and poloxamines in nanoparticle engineering and experimental medicine. Trends in Biotechnol, 18, 412-20. https://doi.org/10.1016/S0167-7799(00)01485-2
- Moghimi SM, Hunter AC, Murray JC (2005). Nanomedicine: current status and future prospects. The FASEB J, 19, 311-30. https://doi.org/10.1096/fj.04-2747rev
- Mohanraj V.J, Chen Y (2007). Nanoparticles-a review. Tropical J Pharm Res, 5, 561-73.
- Moreno D, Zalba S, Navarro I, et al (2010). Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice. Eur J Pharm Biopharm, 74, 265-74. https://doi.org/10.1016/j.ejpb.2009.10.005
- Mosqueira VCF, Legrand P, Gulik A, et al (2001). Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials, 22, 2967-79. https://doi.org/10.1016/S0142-9612(01)00043-6
- Mozafari MR, Pardakhty A, Azarmi S, et al (2009). Role of nanocarrier systems in cancer nanotherapy. J Liposome Res, 19, 310-21. https://doi.org/10.3109/08982100902913204
- Mu L, Feng SS (2003). A novel controlled release formulation for the anticancer drug. J Control Release, 86, 33-48. https://doi.org/10.1016/S0168-3659(02)00320-6
- Mukerjee A, Vishwanatha JK (2009). Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy. Anticancer Res, 29, 3867-75.
- Mundargi RC, Babu VR, Rangaswamy V, et al (2008). Nano/micro technologies for delivering macromolecular therapeutics using poly (d, l-lactide-< i> co-glycolide) and its derivatives. J Control Release, 125, 193-209. https://doi.org/10.1016/j.jconrel.2007.09.013
- Nicoli S, Santi P, Couvreur P, et al (2001). Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Int J Pharm, 214, 31-5. https://doi.org/10.1016/S0378-5173(00)00632-3
- Nie S, Xing Y, Kim GJ, Simons JW (2007). Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng, 9, 257-88. https://doi.org/10.1146/annurev.bioeng.9.060906.152025
-
Nobs L, Buchegger F, Gurny R, Allemann E (2004). Poly (lactic acid) nanoparticles labeled with biologically active
$Neutravidin^{TM}$ for active targeting. Eur J Pharm Biopharm, 58, 483-90. https://doi.org/10.1016/j.ejpb.2004.04.006 - Nobs L, Buchegger F, Gurny R, Allemann E (2006). Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjugate chemistry, 17, 139-45. https://doi.org/10.1021/bc050137k
- Noh WC, Mondesire WH, Peng J, et al (2004). Determinants of rapamycin sensitivity in breast cancer cells. Clinical Cancer Res, 10, 1013-23. https://doi.org/10.1158/1078-0432.CCR-03-0043
- Ong B, Ranganath SH, Lee LY, et al (2009). Paclitaxel delivery from PLGA foams for controlled release in postsurgical chemotherapy against glioblastoma multiforme. Biomaterials, 30, 3189-96. https://doi.org/10.1016/j.biomaterials.2009.02.030
- Owens DE, Peppas NA (2006). Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm, 307, 93-102. https://doi.org/10.1016/j.ijpharm.2005.10.010
- Palmer TN, Caride VJ, Caldecourt MA, Twickler J, Abdullah V (1984). The mechanism of liposome accumulation in infarction. (BBA)-General Subjects, 797, 363-8. https://doi.org/10.1016/0304-4165(84)90258-7
- Panyam J, Labhasetwar V (2012). Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev, 55, 29-47.
- Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V (2003). Fluorescence and electron microscopy probes for cellular and tissue uptake of poly (d, l-lactide-< i> co-glycolide) nanoparticles. Int J Pharm, 262, 1-11. https://doi.org/10.1016/S0378-5173(03)00295-3
- Panyam J, Zhou WENZ, Prabha S, Sahoo SK, Labhasetwar V (2002). Rapid endo-lysosomal escape of poly (DL-lactideco-glycolide) nanoparticles: implications for drug and gene delivery. The FASEB J, 16, 1217-26. https://doi.org/10.1096/fj.02-0088com
-
Park EK, Lee SB, Lee YM (2005). Preparation and characterization of methoxy poly (ethylene glycol)/poly (< i>
$\varepsilon$ -caprolactone) amphiphilic block copolymeric nanospheres for tumor-specific folate-mediated targeting of anticancer drugs. Biomaterial, 26, 1053-61. https://doi.org/10.1016/j.biomaterials.2004.04.008 - Park H, Yang J, Lee J, et al (2009a). Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. Acs Nano, 3, 2919-26. https://doi.org/10.1021/nn900215k
- Park K, Lee S, Kang E, et al (2009b). New generation of multifunctional nanoparticles for cancer imaging and therapy. Advanced functional materials, 19, 1553-66. https://doi.org/10.1002/adfm.200801655
- Park TG (1994). Degradation of poly (D, L-lactic acid) microspheres: effect of molecular weight. J Control Release, 30, 161-73. https://doi.org/10.1016/0168-3659(94)90263-1
- Park TG (1995). Degradation of poly (lactic-co-glycolic acid) microspheres: effect of copolymer composition. Biomaterials, 16, 1123-30. https://doi.org/10.1016/0142-9612(95)93575-X
- Parveen S, Sahoo SK (2008). Polymeric nanoparticles for cancer therapy. J Drug Targeting, 16, 108-23. https://doi.org/10.1080/10611860701794353
- Pasqualini R, Koivunen E, Kain R, et al (2000). Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res, 60, 722-7.
- Pastorino F, Brignole C, Di Paolo D, et al (2006). Targeting Liposomal Chemotherapy via Both Tumor Cell-Specific and Tumor Vasculature-Specific Ligands Potentiates Therapeutic Efficacy. Cancer Res, 66, 10073-82. https://doi.org/10.1158/0008-5472.CAN-06-2117
- Patel NR, Rathi A, Mongayt D, Torchilin VP (2011). Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes. Int J Pharm, 416, 296-9. https://doi.org/10.1016/j.ijpharm.2011.05.082
- Patil SD, Papadmitrakopoulos F, Burgess DJ (2007). Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release, 117, 68-79. https://doi.org/10.1016/j.jconrel.2006.10.013
- Peer D, Karp JM, Hong S, et al (2007). Nanocarriers as an emerging platform for cancer therapy. Nat nanotechnol, 2, 751-60. https://doi.org/10.1038/nnano.2007.387
- Pinto MMM, Sousa EP (2003). Natural and synthetic xanthonolignoids: chemistry and biological activities. Curr Med Chem, 10, 1-12.
- Pinto Reis C, Neufeld RJ, Ribeiro AJ, Veiga F (2006). Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomedicine: Nanotechnol Biol Med, 2, 8-21. https://doi.org/10.1016/j.nano.2005.12.003
- Prior S, Gander B, Blarer N, et al (2002). In vitro phagocytosis and monocyte-macrophage activation with poly (lactide) and poly (lactide-co-glycolide) microspheres. Eur J Pharm Sci, 15, 197-207. https://doi.org/10.1016/S0928-0987(01)00218-4
- Prokop A, Davidson JM (2008). Nanovehicular intracellular delivery systems. J Pharm sci, 97, 3518-90. https://doi.org/10.1002/jps.21270
- Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E (1998). Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Industrial Pharm, 24, 1113-28. https://doi.org/10.3109/03639049809108571
- Ranganath SH, Fu Y, Arifin DY, et al (2010). The use of submicron/nanoscale PLGA implants to deliver paclitaxel with enhanced pharmacokinetics and therapeutic efficacy in intracranial glioblastoma in mice. Biomaterials, 31, 5199-207. https://doi.org/10.1016/j.biomaterials.2010.03.002
- Ratajczak-Enselme M, Estebe JP, Dollo G, et al (2009). Epidural, intrathecal and plasma pharmacokinetic study of epidural ropivacaine in PLGA-microspheres in sheep model. Eur J Pharm Biopharm, 7, 54-61.
- Ratner BD, Johnston AB, Lenk TJ (1987). Biomaterial surfaces. J Biomed Mater Res, 21, 59. https://doi.org/10.1002/jbm.820210110
- Ravi Kumar MNV, Bakowsky U, Lehr CM (2004). Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials, 25, 1771-7. https://doi.org/10.1016/j.biomaterials.2003.08.069
- Reddy LH, Sharma RK, Chuttani K, Mishra AK, Murthy RR (2004). Etoposide-incorporated tripalmitin nanoparticles with different surface charge: formulation, characterization, radiolabeling, and biodistribution studies. The AAPS J, 6, 55-64. https://doi.org/10.1208/aapsj060323
- Ren F, Chen R, Wang Y, et al (2011). Paclitaxel-loaded poly (n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer. Pharm Res, 28, 897-906. https://doi.org/10.1007/s11095-010-0346-9
- Ricci-Junior E, Marchetti JM (2006). Zinc (II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm, 310, 187-95. https://doi.org/10.1016/j.ijpharm.2005.10.048
- Ringsdorf H. Structure and properties of pharmacologically active polymers. J Polym Sci, 51, 135-53.
- Roerdink FH, Dijkstra J, Spanjer HH, Scherphof GL (1984). Interaction of liposomes with hepatocytes and Kupffer cells in vivo and in vitro. Biochem Soc Trans, 12, 335.
- Rosenberg B (2006). Charles F. Kettring prize. Fundamental studies with cisplatin. Cancer, 55, 2303-16.
- Sahoo SK, Labhasetwar V (2003). Nanotech approaches to drug delivery and imaging. Drug Discov Today, 8, 1112-20. https://doi.org/10.1016/S1359-6446(03)02903-9
- Saiki I, Yoneda J, Azuma I, et al (1993). Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Inter J Cancer, 54, 137-43. https://doi.org/10.1002/ijc.2910540122
- Scaltriti M, Baselga J (2006). The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res, 12, 5268-72. https://doi.org/10.1158/1078-0432.CCR-05-1554
- Schliecker G, Schmidt C, Fuchs S, Kissel T (2003). Characterization of a homologous series of D, L-lactic acid oligomers; a mechanistic study on the degradation kinetics in vitro. Biomaterials, 24, 3835-44. https://doi.org/10.1016/S0142-9612(03)00243-6
- Scholes PD, Coombes AGA, Illum L, et al (1993). The preparation of sub-200 nm poly (lactide-co-glycolide) microspheres for site-specific drug delivery. J Control Release, 25, 145-53. https://doi.org/10.1016/0168-3659(93)90103-C
- Shadidi M, Sioud M (2003). Selective targeting of cancer cells using synthetic peptides. Drug Resist Updat, 6, 363-71. https://doi.org/10.1016/j.drup.2003.11.002
- Shah SS, Cha Y, Pitt CG (1992). Poly (glycolic acid-co-DL-lactic acid): diffusion or degradation controlled drug delivery? J Control Release, 18, 261-70. https://doi.org/10.1016/0168-3659(92)90171-M
- Shahani K, Swaminathan SK, Freeman D, et al (2010). Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention. Cancer Res, 70, 4443-52. https://doi.org/10.1158/0008-5472.CAN-09-4362
- Shaikh J, Ankola DD, Beniwal V, Singh D, Kumar MNV (2009). Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci, 37, 223-30. https://doi.org/10.1016/j.ejps.2009.02.019
- Sharma AK, Zhang L, Li S, et al (2008). Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant. J Control Release, 131, 220-7. https://doi.org/10.1016/j.jconrel.2008.07.031
- Sharma G, Italia JL, Sonaje K, et al (2007). Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats. J Control Release, 118, 27-37. https://doi.org/10.1016/j.jconrel.2006.11.026
-
Shenoy D, Little S, Langer R, Amiji M (2005). Poly (ethylene oxide)-modified poly (
$\beta$ -amino ester) nanoparticles as a pHsensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies. Pharm Res, 22, 2107-14. https://doi.org/10.1007/s11095-005-8343-0 - Shishodia S, Sethi G, Aggarwal BB (2005). Curcumin: getting back to the roots. Ann NY Acad Sci, 1056, 206-17. https://doi.org/10.1196/annals.1352.010
- Si-Shen F, Li M, Win KY, Guofeng H (2004). Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem, 11, 413-24. https://doi.org/10.2174/0929867043455909
- Simamora P, Alvarez J.M, Yalkowsky S.H (2001). Solubilization of rapamycin. Int J Pharm, 213, 25-9. https://doi.org/10.1016/S0378-5173(00)00617-7
- Song KC, Lee HS, Choung IY, et al (2006). The effect of type of organic phase solvents on the particle size of poly (D, L-lactide-co-glycolide) nanoparticles. Colloids and Surfaces A: Physicochem Eng Asp, 276, 162-167. https://doi.org/10.1016/j.colsurfa.2005.10.064
- Song X, Zhao Y, Wu W, et al (2008). PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int J Pharm, 350, 320-9. https://doi.org/10.1016/j.ijpharm.2007.08.034
- Song XR, Cai Z, Zheng Y, et al (2009). Reversion of multidrug resistance by co-encapsulation of vincristine and verapamil in PLGA nanoparticles. Eur J Pharm Sci, 37, 300-5. https://doi.org/10.1016/j.ejps.2009.02.018
- Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001). Biodegradable polymeric nanoparticles as drug delivery devices. J Control Release, 70, 1-20. https://doi.org/10.1016/S0168-3659(00)00339-4
- Stolnik S, Illum L, Davis SS (1995). Long circulating microparticulate drug carriers. Adv Drug Deliv Rev, 16, 195-214. https://doi.org/10.1016/0169-409X(95)00025-3
- Storm G, Belliot SO, Daemen T, Lasic DD (1995). Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev, 17, 31-48. https://doi.org/10.1016/0169-409X(95)00039-A
- Studer M, Briel M, Leimenstoll B, Glass TR, Bucher HC (2005). Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med, 165, 725. https://doi.org/10.1001/archinte.165.7.725
- Sun Y, Wang JC, Zhang X, et al (2008). Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies. J Control Release, 129, 192-9. https://doi.org/10.1016/j.jconrel.2008.04.022
- Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006). Targeting multidrug resistance in cancer. Nat Rev Drug Discov, 5, 219-34. https://doi.org/10.1038/nrd1984
- Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y (2009). Improved cellular uptake of chitosanmodified PLGA nanospheres by A549 cells. Int J Pharm, 382, 198-204. https://doi.org/10.1016/j.ijpharm.2009.07.023
- Tang N, Du G, Wang N, et al (2007). Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. J Natl Cancer Inst, 99, 1004-15. https://doi.org/10.1093/jnci/djm027
- Tannock IF, Rotin D (1989). Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res, 49, 4373-84.
- Teicher BA (2000). Molecular targets and cancer therapeutics: discovery, development and clinical validation. Drug Resist Updat, 3, 67-73. https://doi.org/10.1054/drup.2000.0123
- Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM (2005). Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. Eur J Pharm Biopharm, 59, 491-500. https://doi.org/10.1016/j.ejpb.2004.09.002
- Thioune O, Fessi H, Devissaguet JP, Puisieux F (1997). Preparation of pseudolatex by nanoprecipitation: influence of the solvent nature on intrinsic viscosity and interaction constant. Int J Pharm, 146, 233-8. https://doi.org/10.1016/S0378-5173(96)04830-2
- Tice TR, Gilley RM (1985). Preparation of injectable controlledrelease microcapsules by a solvent-evaporation process. J Control Release, 2, 343-52. https://doi.org/10.1016/0168-3659(85)90056-2
- Tobio M, Sanchez A, Vila A, et al (2000). The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration. Colloids and Surfaces B: Biointerfaces, 18, 315-23. https://doi.org/10.1016/S0927-7765(99)00157-5
- Torchilin VP (2000). Drug targeting. Eur J Pharm Sci, 11, S81-S91. https://doi.org/10.1016/S0928-0987(00)00166-4
- Torchilin VP, Trubetskoy VS (1995). Which polymers can make nanoparticulate drug carriers long-circulating? Adv Drug Deliv Rev, 16, 141-55. https://doi.org/10.1016/0169-409X(95)00022-Y
- Ueda M, Iwara A, Kreuter J (1998). Influence of the preparation methods on the drug release behaviour of loperamide-loaded nanoparticles. J Microencapsul, 15, 361-72. https://doi.org/10.3109/02652049809006863
- Utreja P, Jain S, Tiwary AK (2010). Novel drug delivery systems for sustained and targeted delivery of anti-cancer drugs: current status and future prospects. Curr Drug Deliv, 7, 152. https://doi.org/10.2174/156720110791011783
- van Vlerken LE, Amiji MM (2006). Multi-functional polymeric nanoparticles for tumour-targeted drug delivery. Expert Opin Drug Deliv, 3, 205-16. https://doi.org/10.1517/17425247.3.2.205
- Vasir J.K, Labhasetwar V (2007). Biodegradable nanoparticles for cytosolic delivery of therapeutics. Adv Drug Deliv Rev, 59, 718-28. https://doi.org/10.1016/j.addr.2007.06.003
- Vasir JK, Labhasetwar V (2008). Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials, 29, 4244-52. https://doi.org/10.1016/j.biomaterials.2008.07.020
- Vauthier C, Bouchemal K (2009). Methods for the preparation and manufacture of polymeric nanoparticles. Pharm Res, 26, 1025-58. https://doi.org/10.1007/s11095-008-9800-3
- Vert M, Mauduit J, Li S (1994). Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials, 15, 1209-13. https://doi.org/10.1016/0142-9612(94)90271-2
- Vila A, Sanchez A, Tobio M, Calvo P, Alonso MJ (2002). Design of biodegradable particles for protein delivery. J Control Release, 78, 15-24. https://doi.org/10.1016/S0168-3659(01)00486-2
- Wang YM, Sato H, Adachi I, Horikoshi I (1996). Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. Chem Pharm Bull, 44, 1935. https://doi.org/10.1248/cpb.44.1935
- Wickline SA, Neubauer AM, Winter P, Caruthers S, Lanza G (2006). Applications of nanotechnology to atherosclerosis, thrombosis, and vascular biology. Arterioscler Thromb Vasc Biol, 26, 435-41.
- Wickline SA, Neubauer AM, Winter PM, Caruthers SD, Lanza GM (2007). Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.J Magn Reson Imaging, 25, 667-80. https://doi.org/10.1002/jmri.20866
- Wischke C, Schwendeman SP (2008). Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm, 364, 298-327. https://doi.org/10.1016/j.ijpharm.2008.04.042
- Wong HM, Wang JJ, Wang CH (2001). In vitro sustained release of human immunoglobulin G from biodegradable microspheres. Ind Eng Chem Res, 40, 933-48. https://doi.org/10.1021/ie0006256
- Xiong Y, Zeng YS, Zeng CG, et al (2009). Synaptic transmission of neural stem cells seeded in 3-dimensional PLGA scaffolds. Biomaterials, 30, 3711-22. https://doi.org/10.1016/j.biomaterials.2009.03.046
- Xu T, Zhang N, Nichols HL, Shi D, Wen X (2007). Modification of nanostructured materials for biomedical applications. Mater Sci Eng, 27, 579-94. https://doi.org/10.1016/j.msec.2006.05.029
- Yallapu MM, Gupta BK, Jaggi M, Chauhan SC (2010). Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci, 351, 19-29. https://doi.org/10.1016/j.jcis.2010.05.022
- Yang A, Yang L, Liu W, et al (2007). Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: Preparation and< i> in vitro evaluation. Int J Pharm, 331, 123-32. https://doi.org/10.1016/j.ijpharm.2006.09.015
- Yezhelyev MV, Gao X, Xing Y, et al (2006). Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol, 7, 657-67. https://doi.org/10.1016/S1470-2045(06)70793-8
- Yoo HS, Lee KH, Oh JE, Park TG (2000). In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin- PLGA conjugates. J Control Release, 68, 419-31. https://doi.org/10.1016/S0168-3659(00)00280-7
- Zambaux MF, Bonneaux F, Gref R, et al (1998). Influence of experimental parameters on the characteristics of poly (lactic acid) nanoparticles prepared by a double emulsion method. J Control Release, 50, 31-40. https://doi.org/10.1016/S0168-3659(97)00106-5
- Zeisser-Labouebe M, Lange N, Gurny R, Delie F (2006). Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm, 326, 174-81. https://doi.org/10.1016/j.ijpharm.2006.07.012
- Zhang H, Cui W, Bei J, Wang S (2006). Preparation of poly (lactide-< i> co-glycolide-< i> co-caprolactone) nanoparticles and their degradation behaviour in aqueous solution. Polym Degrad Stab, 91, 1929-36. https://doi.org/10.1016/j.polymdegradstab.2006.03.004
- Zhang Z, Feng SS (2006). The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials, 27, 4025-33. https://doi.org/10.1016/j.biomaterials.2006.03.006
- Zhu G, Schwendeman SP (2000). Stabilization of proteins encapsulated in cylindrical poly (lactide-co-glycolide) implants: mechanism of stabilization by basic additives. Pharm Res, 17, 351-7. https://doi.org/10.1023/A:1007513425337
Cited by
- Nanoparticle Induced Oxidative Stress in Cancer Cells: Adding New Pieces to an Incomplete Jigsaw Puzzle vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4739
- Trichostatin A-induced Apoptosis is Mediated by Krüppel-like Factor 4 in Ovarian and Lung Cancer vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6581
- Preparation of 5-fluorouracil-loaded Nanoparticles and Study of Interaction with Gastric Cancer Cells vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7611
- Implementation of Proteomics for Cancer Research: Past, Present, and Future vol.15, pp.6, 2014, https://doi.org/10.7314/APJCP.2014.15.6.2433
- Current Status and Future Perspectives of Sonodynamic Therapy and Sonosensitiers vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4489
- Preparation and Evaluation of Chrysin Encapsulated in PLGA-PEG Nanoparticles in the T47-D Breast Cancer Cell Line vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3753
- Engineering Biomaterial–Drug Conjugates for Local and Sustained Chemotherapeutic Delivery vol.26, pp.7, 2015, https://doi.org/10.1021/acs.bioconjchem.5b00046
- Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity vol.291, pp.17, 2016, https://doi.org/10.1074/jbc.M115.695304
- New approaches to targeted drug delivery to tumour cells vol.84, pp.1, 2015, https://doi.org/10.1070/RCR4468
- Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines pp.2169-141X, 2015, https://doi.org/10.3109/21691401.2015.1008510
- Biomedical and biological applications of quantum dots pp.2169-141X, 2015, https://doi.org/10.3109/21691401.2014.998826
- Magnetic nanoparticles as potential candidates for biomedical and biological applications pp.2169-141X, 2015, https://doi.org/10.3109/21691401.2014.998832
- Magnetic nanoparticles: Applications in gene delivery and gene therapy pp.2169-141X, 2015, https://doi.org/10.3109/21691401.2015.1014093
- Anthracycline Drugs on Modified Surface of Quercetin-Loaded Polymer Nanoparticles: A Dual Drug Delivery Model for Cancer Treatment vol.11, pp.5, 2016, https://doi.org/10.1371/journal.pone.0155710
- Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy vol.116, pp.5, 2016, https://doi.org/10.1021/acs.chemrev.5b00148
- Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8259
- Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate vol.17, pp.2, 2016, https://doi.org/10.1208/s12249-015-0354-5
- Drug delivery and nanodetection in lung cancer vol.44, pp.2, 2016, https://doi.org/10.3109/21691401.2014.975237
- Current methods for synthesis of magnetic nanoparticles vol.44, pp.2, 2016, https://doi.org/10.3109/21691401.2014.982802
- Improved Treatment of Pancreatic Cancer With Drug Delivery Nanoparticles Loaded With a Novel AKT/PDK1 Inhibitor vol.45, pp.8, 2016, https://doi.org/10.1097/MPA.0000000000000607
- Multifunctional PLGA/Parylene C Coating for Implant Materials: An Integral Approach for Biointerface Optimization vol.8, pp.34, 2016, https://doi.org/10.1021/acsami.6b08025
- Studying the effect of physically-adsorbed coating polymers on the cytotoxic activity of optimized bisdemethoxycurcumin loaded-PLGA nanoparticles vol.105, pp.5, 2017, https://doi.org/10.1002/jbm.a.36028
- A growing world of small things: a brief review on the nanostructured vaccines vol.12, pp.12, 2017, https://doi.org/10.2217/fvl-2017-0086
- -glycolic) Acid Microparticles Fabricated by Coaxial Electrospray: Validation of Enhanced Encapsulation Efficiency and Bioavailability vol.14, pp.12, 2017, https://doi.org/10.1021/acs.molpharmaceut.7b00862
- Hydrogel-based three-dimensional cell culture for organ-on-a-chip applications vol.33, pp.3, 2017, https://doi.org/10.1002/btpr.2457
- Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line vol.45, pp.3, 2017, https://doi.org/10.3109/21691401.2016.1160915
- A polymeric temozolomide nanocomposite against orthotopic glioblastoma xenograft: tumor-specific homing directed by nestin vol.9, pp.30, 2017, https://doi.org/10.1039/C7NR00305F
- Paclitaxel-loaded PLA/PEG/fluorescein anticancer agent prepared by Ugi reaction pp.1563-535X, 2018, https://doi.org/10.1080/00914037.2017.1378884
- Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells pp.2169-141X, 2017, https://doi.org/10.1080/21691401.2017.1347879
- Development and characterization dual responsive magnetic nanocomposites for targeted drug delivery systems pp.2169-141X, 2017, https://doi.org/10.1080/21691401.2017.1360323
- Nanoparticle-Mediated Expression of a Wnt Pathway Inhibitor Ameliorates Ocular Neovascularization vol.35, pp.4, 2015, https://doi.org/10.1161/ATVBAHA.114.304627
- Bacterial-Derived Polymer Poly-y-Glutamic Acid (y-PGA)-Based Micro/Nanoparticles as a Delivery System for Antimicrobials and Other Biomedical Applications vol.18, pp.2, 2017, https://doi.org/10.3390/ijms18020313
- Covalent modification of pericardial patches for sustained rapamycin delivery inhibits venous neointimal hyperplasia vol.7, pp.1, 2017, https://doi.org/10.1038/srep40142
- evaluation of magnetic nanoparticles modified with PCL–PEG–PCL for controlled delivery of 5FU pp.2169-141X, 2018, https://doi.org/10.1080/21691401.2018.1439839
- Nanoscale modification of chrysin for improved of therapeutic efficiency and cytotoxicity pp.2169-141X, 2018, https://doi.org/10.1080/21691401.2018.1434661
- PLGA-Based Nanoparticles in Cancer Treatment vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.01260
- Universal influenza vaccines: from viruses to nanoparticles vol.17, pp.11, 2018, https://doi.org/10.1080/14760584.2018.1541408
- -glycolic acid) nanoparticles for targeted therapy of miR-21-inhibited ovarian cancer cells vol.13, pp.21, 2018, https://doi.org/10.2217/nnm-2018-0205
- Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells pp.15524973, 2018, https://doi.org/10.1002/jbm.b.34208
- Evaluation of the Uptake of PLGA-PEG Nanoparticles by Human Cancer Cells vol.13, pp.1-2, 2018, https://doi.org/10.1134/S1995078018010147
- Preparation of Poly (dl-Lactide-co-Glycolide) Nanoparticles Encapsulated with Periglaucine A and Betulinic Acid for In Vitro Anti-Acanthamoeba and Cytotoxicity Activities vol.7, pp.3, 2018, https://doi.org/10.3390/pathogens7030062
- Itraconazole encapsulated PLGA-nanoparticles covered with mannose as potential candidates against leishmaniasis pp.15524973, 2018, https://doi.org/10.1002/jbm.b.34161
- Gamma oryzanol loaded microspheres with improved bioavailability vol.12, pp.17, 2018, https://doi.org/10.5897/AJPP2018.4914
- Design and evaluation of glomerulus mesangium-targeted PEG-PLGA nanoparticles loaded with dexamethasone acetate pp.1745-7254, 2018, https://doi.org/10.1038/s41401-018-0052-4
- Construction of PLGA/JNK3-shRNA nanoparticles and their protective role in hippocampal neuron apoptosis induced by oxygen and glucose deprivation vol.8, pp.36, 2018, https://doi.org/10.1039/C8RA00679B
- Small PLGA nanocapsules Co-encapsulating copper sulfide nanodots and fluorocarbon compound for photoacoustic imaging-guided HIFU synergistic therapy vol.8, pp.9, 2018, https://doi.org/10.1039/C7RA12074E
- Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles vol.18, pp.1, 2018, https://doi.org/10.1186/s12885-018-4393-7
- Comparative evaluation of hesperetin loaded nanoparticles for anticancer activity against C6 glioma cancer cells vol.47, pp.1, 2019, https://doi.org/10.1080/21691401.2018.1556213